Page last updated: 2024-10-23

5-methoxypsoralen and Cutaneous T-Cell Lymphoma

5-methoxypsoralen has been researched along with Cutaneous T-Cell Lymphoma in 2 studies

5-Methoxypsoralen: A linear furanocoumarin that has phototoxic and anti-inflammatory properties, with effects similar to METHOXSALEN. It is used in PUVA THERAPY for the treatment of PSORIASIS.
5-methoxypsoralen : A 5-methoxyfurocoumarin that is psoralen substituted by a methoxy group at position 5.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wolf, P1
Müllegger, R1
Cerroni, L1
Aigner, R1
Fueger, G1
Höfler, G1
Derbaschnig, J1
Kerl, H1
Shephard, SE1
Panizzon, RG1

Other Studies

2 other studies available for 5-methoxypsoralen and Cutaneous T-Cell Lymphoma

ArticleYear
Photoaccentuated erythroderma associated with CD4+ T lymphocytopenia: successful treatment with 5-methoxypsoralen and UVA, interferon alfa-2b, and extracorporeal photopheresis.
    Journal of the American Academy of Dermatology, 1996, Volume: 35, Issue:2 Pt 2

    Topics: 5-Methoxypsoralen; Dermatitis, Exfoliative; HIV Seronegativity; Humans; Interferon alpha-2; Interfer

1996
Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
    Dermatology (Basel, Switzerland), 1999, Volume: 199, Issue:2

    Topics: 5-Methoxypsoralen; Administration, Oral; Administration, Topical; Baths; DNA Adducts; Female; Humans

1999